Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Madison A. Clark
Observed name:
Madison A Clark
Institution:
Medical University of South Carolina
Observed institution:
Medical University of South Carolina
ORCID:
0009-0000-0319-1656
Observed ORCID:
0009-0000-0319-1656
OpenAlex ID:
A5108991582
MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
·
Cancer Research Communications
·
8
Metallothionein loss in cancer cells contributes to increased mutations through defective DNA repair and metabolic imbalance
2026
·
Mirna Mina-Abouda
, Amy C Rees
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Supplementary Figure 3 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2025
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 5 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2025
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 7 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2025
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Table 1 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2025
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 4 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2025
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 2 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2025
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 6 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2025
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 1 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2025
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 6 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 3 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 7 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 2 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 4 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Figure 6 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Table 1 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Data from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Figure 2 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Table 1 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Supplementary Figure 5 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
PDF
Supplementary Figure 1 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Figure 1 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Figure 6 from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Data from MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model
2024
·
Alexandra Blackman
, Amy C. Rees
, et al.
Show more works
View as search
Works count:
29
Citation count:
8
H-index:
1
I10-index:
Year
Topic
Type